Home
Conditions
Amphetamine-Related Disorders

Clinical trial condition

Amphetamine-Related Disorders

Explore clinical trials studying Amphetamine-Related Disorders. Study availability and eligibility vary by location and protocol.

21 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Amphetamine-Related Disorders trial results

Completed

Long-term Behavior Change - 1

NCT00158197

Conditions: Amphetamine-Related Disorders, Behavior, Chemically-Induced Disorders, +3 more
Locations: Friends Research Institute Los Angeles, California, United States

Friends Research Institute Rancho Cucamonga, California, United States

View Trial Details

Completed

Abuse Liability and Human Pharmacology of Mephedrone

NCT02232789

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +1 more
Locations: Institut Hospital del Mar d'Investigacions Mèdiques-IMIM. Parc de Salut Mar. Barcelona, Spain

View Trial Details

Completed

Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)

NCT01136278

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: Clinical Pharmacology & Toxicology, University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

NCT00886886

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: University Hospital Basel, Switzerland

View Trial Details

Completed

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

NCT00990067

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: Clinical Pharmacology & Toxicology, University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging

NCT01296802

Conditions: Amphetamine Abuse, Amphetamine-Related Disorders, Chemically-Induced Disorders, +5 more
Locations: University Hospital of Psychiatry Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Functional Brain Imaging in Recreational Users of Ecstasy

NCT00254306

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +1 more
Locations: Dept. of Nuclear Medicine, Hadassah Hospital, Ein Kerem Jerusalem, Israel

View Trial Details

Completed

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

NCT00895804

Conditions: Amphetamine-Related Disorders, Chemically-Induced Disorders, Mental Disorders, +4 more
Locations: Heffter Research Center, University Hospital of Psychiatry Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

NCT00248092

Conditions: Amphetamine-Related Disorders, Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, +6 more
Locations: Johns Hopkins Bayview Medical Center, Clinical Studies Program Baltimore, Maryland, United States

View Trial Details

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

NCT00247572

Conditions: Amphetamine-Related Disorders, Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, +7 more
Locations: Johns Hopkins Bayview Medical Center, Clinical Studies Program Baltimore, Maryland, United States

View Trial Details

Amphetamine-Related Disorders

Amphetamine-Related Disorders trial results

Related conditions